U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MEZAGITAMAB
0XMR8L9LOL
Investigational
General
Names
9
Classification
2
Identifiers
5
Subunits
4
Related Substances
1
MEZAGITAMAB
0XMR8L9LOL
Investigational
General
Approval Year
Unknown
139,594
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MEZAGITAMAB
Official Name
English
TAK079
Code
English
mezagitamab [INN]
Common Name
English
Mezagitamab [WHO-DD]
Common Name
English
TAK-079
Code
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of multiple myeloma
FDA ORPHAN DRUG
667418
Designated
ORPHAN DRUG
Designated
Treatment of myasthenia gravis
FDA ORPHAN DRUG
905822
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
5
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
HI-208
PRIMARY
NCI_THESAURUS
C148078
PRIMARY
CAS
2227490-52-8
PRIMARY
FDA UNII
0XMR8L9LOL
PRIMARY
INN
11159
PRIMARY
Showing 1 to 5 of 5 entries
Previous
1
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
0XMR8L9LOL
MEZAGITAMAB